T Amsrud Selected Research

T Amsrud Research Topics

3	Neoplasms (Cancer) 07/2000 - 01/2000
2	Carcinoma (Carcinomatosis) 07/2000 - 01/2000
2	Breast Neoplasms (Breast Cancer) 03/2000 - 01/2000
1	Lung Neoplasms (Lung Cancer) 07/2000
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 07/2000
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2000
1	Body Weight (Weight, Body) 03/2000

3	Fluorouracil (Carac)FDA LinkGeneric 07/2000 - 01/2000
3	Gemcitabine FDA Link 07/2000 - 01/2000
2	Paclitaxel (Taxol)FDA LinkGeneric 07/2000 - 01/2000
2	DepsipeptidesIBA 07/2000 - 01/2000
2	cryptophycin 55IBA 07/2000 - 01/2000
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 03/2000 - 01/2000
2	Cisplatin (Platino)FDA LinkGeneric 03/2000 - 01/2000
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 03/2000 - 01/2000
2	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2000 - 01/2000
1	Docetaxel (Taxotere)FDA Link 07/2000
1	Irinotecan (Camptosar)FDA LinkGeneric 07/2000
1	cryptophycin 52 (cryptophycin-52)IBA 07/2000
1	Pemetrexed (MTA)FDA Link 03/2000
1	Antineoplastic Agents (Antineoplastics)IBA 03/2000
1	Folic Acid AntagonistsIBA 03/2000
1	6R- 2',5'- thienyl- 5,10- dideazatetrahydrofolic acidIBA 03/2000
1	Methotrexate (Mexate)FDA LinkGeneric 03/2000
1	cryptophycin 292IBA 01/2000
1	Saline SolutionIBA 01/2000
1	PlatinumIBA 01/2000
1	Carboplatin (JM8)FDA LinkGeneric 01/2000
1	cremophorIBA 01/2000

2	Radiotherapy 07/2000 - 03/2000
1	Catheters 01/2000